Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $425,541 - $555,336
2,264 New
2,264 $445,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $50,718 - $69,650
278 Added 14.81%
2,155 $424,000
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $383,152 - $567,604
1,877 New
1,877 $402,000
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $369,467 - $523,611
-1,446 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $4.32 Million - $5.52 Million
-12,296 Reduced 89.48%
1,446 $545,000
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $4.06 Million - $4.99 Million
10,886 Added 381.16%
13,742 $5.67 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $840,149 - $1.06 Million
2,856 New
2,856 $1.06 Million
Q1 2021

May 06, 2021

SELL
$249.67 - $299.48 $960,230 - $1.15 Million
-3,846 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $853,812 - $971,576
3,846 New
3,846 $961,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $998,234 - $1.29 Million
-5,686 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $675,724 - $1.08 Million
5,686 New
5,686 $991,000
Q3 2019

Nov 12, 2019

SELL
$125.07 - $143.67 $1.26 Million - $1.45 Million
-10,088 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $1.24 Million - $1.5 Million
10,088 New
10,088 $1.43 Million
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $1.55 Million - $2.17 Million
-14,772 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$105.09 - $137.23 $1.55 Million - $2.03 Million
14,772 New
14,772 $1.67 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.41B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.